{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:48:08Z","timestamp":1772430488059,"version":"3.50.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Health and Medical Care Executive Board"},{"name":"V\u00e4stra G\u00f6taland","award":["VGFOUREG-383071"],"award-info":[{"award-number":["VGFOUREG-383071"]}]},{"name":"V\u00e4stra G\u00f6taland","award":["VGFOUREG-564511"],"award-info":[{"award-number":["VGFOUREG-564511"]}]},{"name":"V\u00e4stra G\u00f6taland","award":["VGFOUREG-754661"],"award-info":[{"award-number":["VGFOUREG-754661"]}]},{"DOI":"10.13039\/501100001862","name":"The Swedish Research Council","doi-asserted-by":"crossref","award":["2016\u201302035"],"award-info":[{"award-number":["2016\u201302035"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Association Against Rheumatism"},{"name":"The Swedish Association Against Rheumatism"},{"name":"The Swedish Society of Medicine"},{"name":"The G\u00f6teborg Medical Society"},{"DOI":"10.13039\/100001424","name":"ALF","doi-asserted-by":"publisher","award":["ALFGBG-141111"],"award-info":[{"award-number":["ALFGBG-141111"]}],"id":[{"id":"10.13039\/100001424","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001424","name":"ALF","doi-asserted-by":"publisher","award":["ALFGBG-430851"],"award-info":[{"award-number":["ALFGBG-430851"]}],"id":[{"id":"10.13039\/100001424","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001424","name":"ALF","doi-asserted-by":"publisher","award":["ALFVLL-640251"],"award-info":[{"award-number":["ALFVLL-640251"]}],"id":[{"id":"10.13039\/100001424","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Controlling Chronic Inflammatory Diseases"},{"DOI":"10.13039\/501100008090","name":"Margareta Rheuma research foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To study baseline serum hepatocyte growth factor (s-HGF) as a predictor of spinal radiographic progression overall and by sex and to analyse factors correlated to changes in s-HGF in patients with AS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>At baseline and the 5-year follow-up, s-HGF was analysed with ELISA. Spinal radiographs were graded according to modified Stoke Ankylosing Spondylitis Spinal Score. Radiographic progression was defined as \u22652 modified Stoke Ankylosing Spondylitis Spinal Score units\/5\u2009years or development of \u22651 syndesmophyte. Logistic regression analyses were used.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 204 baseline participants, 163 (80%) completed all examinations at the 5-year follow-up (54% men). Baseline s-HGF was significantly higher in men who developed \u22651 syndesmophyte compared with non-progressors, median (interquartile range) baseline s-HGF 1551 (1449\u20131898) vs 1436 (1200\u20131569) pg\/ml, P\u2009=\u20090.003. The calculated optimal cut-off point for baseline s-HGF \u22651520\u2009pg\/ml showed a sensitivity of 70%, a specificity of 69% and univariate odds radio (95% CI) of 5.25 (1.69, 14.10) as predictor of development of \u22651 new syndesmophyte in men. Baseline s-HGF \u22651520\u2009pg\/ml remained significantly associated with development of \u22651 new syndesmophyte in men in an analysis adjusted for the baseline variables age, smoking, presence of syndesmophytes and CRP, odds radio 3.97 (1.36, 11.60). In women, no association with HGF and radiographic progression was found. Changes in s-HGF were positively correlated with changes in ESR and CRP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this prospective cohort study elevated s-HGF was shown to be associated with development of new syndesmophytes in men with AS.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa460","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T11:15:07Z","timestamp":1593774907000},"page":"1804-1813","source":"Crossref","is-referenced-by-count":4,"title":["Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6423-1623","authenticated-orcid":false,"given":"Anna","family":"Deminger","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Region V\u00e4stra G\u00f6taland, Sahlgrenska University Hospital, Department of Rheumatology, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Klingberg","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Region V\u00e4stra G\u00f6taland, Sahlgrenska University Hospital, Department of Rheumatology, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merja","family":"Nurkkala","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Geijer","sequence":"additional","affiliation":[{"name":"Department of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Region V\u00e4stra G\u00f6taland, Sahlgrenska University Hospital, Department of Radiology, Gothenburg, Sweden"},{"name":"Department of Clinical Sciences, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Carlsten","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Region V\u00e4stra G\u00f6taland, Sahlgrenska University Hospital, Department of Rheumatology, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennart T H","family":"Jacobsson","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Forsblad-d\u2019Elia","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Public Health and Clinical Medicine, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"2021040620380263000_keaa460-B1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/ard.2008.091793","article-title":"Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine","volume":"68","author":"Landewe","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021040620380263000_keaa460-B2","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1136\/ard.2009.124206","article-title":"Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis","volume":"69","author":"Machado","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2021040620380263000_keaa460-B3","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/ard.2006.066415","article-title":"Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes","volume":"66","author":"Baraliakos","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2021040620380263000_keaa460-B4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/annrheumdis-2011-200411","article-title":"Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study","volume":"71","author":"van Tubergen","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2021040620380263000_keaa460-B5","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/art.33465","article-title":"Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis","volume":"64","author":"Poddubnyy","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2021040620380263000_keaa460-B6","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3899\/jrheum.080871","article-title":"The natural course of radiographic progression in ankylosing spondylitis\u2014evidence for major individual variations in a large proportion of patients","volume":"36","author":"Baraliakos","year":"2009","journal-title":"J Rheumatol"},{"key":"2021040620380263000_keaa460-B7","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.38070","article-title":"The impact of tumor necrosis factor \u03b1 inhibitors on radiographic progression in ankylosing spondylitis","volume":"65","author":"Haroon","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2021040620380263000_keaa460-B8","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1136\/annrheumdis-2014-205178","article-title":"Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort","volume":"73","author":"Ramiro","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2021040620380263000_keaa460-B9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fimmu.2019.00305","article-title":"Biomarkers for diagnosis of axial spondyloarthritis, disease activity, prognosis, and prediction of response to therapy","volume":"10","author":"Maksymowych","year":"2019","journal-title":". Front Immunol"},{"key":"2021040620380263000_keaa460-B10","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2183\/pjab.86.588","article-title":"The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine","volume":"86","author":"Nakamura","year":"2010","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"2021040620380263000_keaa460-B11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.autrev.2014.11.013","article-title":"Hepatocyte growth factor: a regulator of inflammation and autoimmunity","volume":"14","author":"Molnarfi","year":"2015","journal-title":"Autoimmun Rev"},{"key":"2021040620380263000_keaa460-B12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1083\/jcb.119.3.629","article-title":"Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth","volume":"119","author":"Bussolino","year":"1992","journal-title":"J Cell Biol"},{"key":"2021040620380263000_keaa460-B13","first-page":"82","article-title":"Biology of MET: a double life between normal tissue repair and tumor progression","volume":"3","author":"Petrini","year":"2015","journal-title":"Ann Transl Med"},{"key":"2021040620380263000_keaa460-B14","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1073\/pnas.93.15.7644","article-title":"Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro","volume":"93","author":"Grano","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021040620380263000_keaa460-B15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00198-018-4721-4","article-title":"Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis","volume":"30","author":"Torres","year":"2019","journal-title":"Osteoporos Int"},{"key":"2021040620380263000_keaa460-B16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"2021040620380263000_keaa460-B17","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/ar3833","article-title":"Osteoporosis in ankylosing spondylitis \u2013 prevalence, risk factors and methods of assessment","volume":"14","author":"Klingberg","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2021040620380263000_keaa460-B18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13075-018-1665-1","article-title":"A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis","volume":"20","author":"Deminger","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2021040620380263000_keaa460-B19","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021040620380263000_keaa460-B20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00043764-199101000-00010","article-title":"Use of population-based data to assess risk factor profiles of blue and white collar workers","volume":"33","author":"Niknian","year":"1991","journal-title":"J Occup Environ Med"},{"key":"2021040620380263000_keaa460-B21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/ard.2010.133488","article-title":"ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials\/epidemiological studies in axial spondyloarthritis","volume":"70","author":"Dougados","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021040620380263000_keaa460-B22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.2004.020503","article-title":"Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system","volume":"64","author":"Creemers","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2021040620380263000_keaa460-B23","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1210\/endo.140.3.6553","article-title":"Fibroblast growth factor-2 induces hepatocyte growth factor\/scatter factor expression in osteoblasts","volume":"140","author":"Blanquaert","year":"1999","journal-title":"Endocrinology"},{"key":"2021040620380263000_keaa460-B24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/PL00005831","article-title":"Cortisol decreases hepatocyte growth factor levels in human osteoblast-like cells","volume":"66","author":"Skrtic","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"2021040620380263000_keaa460-B25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1210\/me.2013-1286","article-title":"Hepatocyte growth factor and p38 promote osteogenic differentiation of human mesenchymal stem cells","volume":"28","author":"Aenlle","year":"2014","journal-title":"Mol Endocrinol"},{"key":"2021040620380263000_keaa460-B26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S8756-3282(02)00820-7","article-title":"Cooperative actions of hepatocyte growth factor and 1,25-dihydroxyvitamin D3 in osteoblastic differentiation of human vertebral bone marrow stromal cells","volume":"31","author":"D\u2019ippolito","year":"2002","journal-title":"Bone"},{"key":"2021040620380263000_keaa460-B27","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1007\/s11999-008-0493-z","article-title":"Percutaneous nonviral delivery of hepatocyte growth factor in an osteotomy gap promotes bone repair in rabbits: a preliminary study","volume":"466","author":"Matsubara","year":"2008","journal-title":"Clin Orthop Relat Res"},{"key":"2021040620380263000_keaa460-B28","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1182\/blood-2006-07-034884","article-title":"HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma","volume":"109","author":"Standal","year":"2007","journal-title":"Blood"},{"key":"2021040620380263000_keaa460-B29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2017.03.032","article-title":"Chemical inhibitors of c-Met receptor tyrosine kinase stimulate osteoblast differentiation and bone regeneration","volume":"806","author":"Kim","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"2021040620380263000_keaa460-B30","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1517\/14728222.2016.1162293","article-title":"Hepatocyte growth factor and alternative splice variants\u2014expression, regulation and implications in osteogenesis and bone health and repair","volume":"20","author":"Frisch","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"2021040620380263000_keaa460-B31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/art.40661","article-title":"Impact of tumor necrosis factor inhibitor versus nonsteroidal antiinflammatory drug treatment on radiographic progression in early ankylosing spondylitis: its relationship to inflammation control during treatment","volume":"71","author":"Park","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2021040620380263000_keaa460-B32","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar3857","article-title":"Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis","volume":"14","author":"Mattey","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2021040620380263000_keaa460-B33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/030097401316909585","article-title":"Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis","volume":"30","author":"Feuerherm","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"2021040620380263000_keaa460-B34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.5152\/eajm.2014.41","article-title":"Association between hepatocyte growth factor (HGF) gene polymorphisms and serum HGF levels in patients with rheumatoid arthritis","volume":"46","author":"Kara","year":"2014","journal-title":"Eurasian J Med"},{"key":"2021040620380263000_keaa460-B35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00005176-200111000-00007","article-title":"Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease","volume":"33","author":"Srivastava","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021040620380263000_keaa460-B36","first-page":"445","article-title":"Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity","volume":"12","author":"Robak","year":"2001","journal-title":"Eur Cytokine Netw"},{"key":"2021040620380263000_keaa460-B37","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/art.30163","article-title":"Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis","volume":"63","author":"Grandaunet","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2021040620380263000_keaa460-B38","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/art.1780390917","article-title":"Hepatocyte growth factor. A cytokine mediating endothelial migration in inflammatory arthritis","volume":"39","author":"Koch","year":"1996","journal-title":"Arthritis Rheum"},{"key":"2021040620380263000_keaa460-B39","first-page":"2184","article-title":"Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells","volume":"21","author":"Yukioka","year":"1994","journal-title":"J Rheumatol"},{"key":"2021040620380263000_keaa460-B40","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrm3012","article-title":"MET signalling: principles and functions in development, organ regeneration and cancer","volume":"11","author":"Trusolino","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2021040620380263000_keaa460-B41","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.4049\/jimmunol.179.8.5504","article-title":"Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice","volume":"179","author":"Okunishi","year":"2007","journal-title":"J Immunol"},{"key":"2021040620380263000_keaa460-B42","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3892\/ijmm.2014.1686","article-title":"Intramuscular injection of adenoviral hepatocyte growth factor at a distal site ameliorates dextran sodium sulfate-induced colitis in mice","volume":"33","author":"Yuge","year":"2014","journal-title":"Int J Mol Med"},{"key":"2021040620380263000_keaa460-B43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.metabol.2015.10.023","article-title":"Circulating level of hepatocyte growth factor predicts incidence of type 2 diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"65","author":"Bancks","year":"2016","journal-title":"Metabolism"},{"key":"2021040620380263000_keaa460-B44","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/art.22589","article-title":"Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis","volume":"56","author":"Maksymowych","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021040620380263000_keaa460-B45","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/annrheumdis-2014-205506","article-title":"Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis","volume":"73","author":"Turina","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2021040620380263000_keaa460-B46","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/rheumatology\/kez025","article-title":"Added value of biomarkers compared with clinical parameters for the prediction of radiographic spinal progression in axial spondyloarthritis","volume":"58","author":"Rademacher","year":"2019","journal-title":"Rheumatology"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/4\/1804\/36913491\/keaa460.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/4\/1804\/36913491\/keaa460.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T04:35:40Z","timestamp":1723178140000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/4\/1804\/5940679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,10,27]]},"published-print":{"date-parts":[[2021,4,6]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa460","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,10,27]]}}}